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Advanced Imaging Specialists
Introduction
More than 40,000 women die from breast cancer in the
United States annually. Screening mammography
provides the largest-magnitude reduction
in breast cancer; improving breast cancer
survival through early detection. Annual screening for
women begins at age 40. Triple negative breast cancer
(TNBC) is an inherently-aggressive phenotype that is
more difficult to detect on mammography and has
lower survival compared to non-TNBC, even when
detected early. TNBC is also twice as common among
African American (AA) women compared to
White American (WA) women, thereby contributing to
the higher breast cancer mortality rates observed in AA
women. The role of screening mammography in
addressing breast cancer disparities is therefore worthy of
study.
(Bayard, et al., 2021)

Purpose of Mammography
• Early detection of breast abnormalities and cancer
which aids in early intervention procedures.
• Breast cancer patient survival rate has improved
from 75% to 90% with the help of early detection
(Long, 2018)

Statistics

Screening Mammogram Indications
• Women should begin getting screening
mammograms starting at age 40
• Patient is asymptomatic
• Contains CC (superior to inferior or craniocaudal) and
MLO (mediolateral oblique) views on both breasts
Diagnostic Mammogram Indications
• Patient presents an issue such as:
• Pain
• Palpable lump
• Calcifications
• Special images required depending on the issue
presented
• Magnification views: magnifies area of
interest
• Tangential views: area of interest in
profile
• Spot views: uses smaller compression
paddle for increased pressure on area of
interest
• ML: medial to lateral side of breast or
LM: lateral to medial side of breast
(Long, 2018)

•TNBC accounts for 10% of all breast cancers
•TNBC is most common in women who are
-Younger than 40 years of age
-African American (20% who have breast
cancer
have TNBC)
•Women who contain the BRCA1 mutation are also most
likely to develop TNBC
-BRCA is important for defense against cancer
-If a mutation is present, the patient is more susceptible
to TNBC
(Triple Negative Breast Cancer, 2022)

Image of Normal Mammogram

Mammography Procedure
•Specialized Imaging modality
•Uses digital breast tomosynthesis (DBT) to obtain 3D
images of the breasts
•Breast is compressed by compression paddle to
immobilize patient and to allow for even distribution of
breast tissue
•During the short scan, the x-ray tube arches over the
compressed breast and obtains multiple low-dose images
•Result: multiple slices of breast tissue
(Long, 2018)

Methods for Diagnosis

Types of Mammograms

Stages of Breast Cancer & Survival Rates
•Localized
-No sign cancer has spread outside of breast
•Regional
-Cancer has spread to nearby structures and/or lymph
nodes
•Distant
-Cancer has spread to distant parts of body
Survival Rate over 5 years
•Localized: 91%
•Regional: 65%
•Distant: 12%
(Triple Negative Breast Cancer, 2022)

Image of TNBC
This image presents a 50-year old woman that complained of a
palpable mass in left breast

(Radiopaedia, 2021)

Triple-Negative Breast Cancer (TNBC)
•Triple-Negative Breast Cancer (TNBC) is an invasive
breast cancer absent of estrogen receptor, progesterone
receptor, and HER2 protein
•TNBC is more aggressive than other types of breast
cancer, difficult to treat, and patients are more likely to
have a recurrence
•Mostly basal cell-like in appearance
(Sheng, 2022)

(The Wave, 2021)

(Advanced Science News, 2012)

Diagnostic mammogram
•Searching for calcifications and/or masses
Ultrasound
•Performed if there is a palpable mass that is not present
on the diagnostic mammogram
Breast MRI
•Highly efficient for detection of breast cancer
•Preferred for diagnosis if the patient has a large family
history of breast cancer
•Determines severity of carcinoma
Biopsy
(Dass, et al., 2021)

Treatment
•TNBC has few treatment options
•Immunotherapy
-Promising treatment
-Consists of immune checkpoint inhibitors
-Sometimes combined with chemotherapy (depending
on severity)
•Chemotherapy in combination with surgery
-Surgery includes a lumpectomy or mastectomy
-Chemo will reduce tumor size and surgery will
remove tumor from breast
-Chemo may be administered after to reduce a
recurrence of TNBC
(Keenan & Tolaney, 2020)

Prognosis
•TNBC typically has a poor prognosis when compared to
other types of breast cancer
•Even with early detection, TNBC proliferates rapidly
and does not respond to normal treatments
•TNBC also has a greater chance of recurrence
(Sheng, 2022)

Conclusion
(Radiopaedia, 2021)

Symptoms
TNBC presents the same symptoms as most invasive breast
cancers:
•Swelling of breast
•Skin dimpling
•Pain within the breast or nipple
•Breast skin that is red or flaking
•Discharge from nipples
•Swollen axillary lymph nodes
(Triple Negative Breast Cancer, 2022)

Mammography is a specialized imaging modality that
allows for early detection of breast cancer. The
mammographic x-ray tube takes multiple images of each
breast which results in a greater volume of breast tissue to
be viewed. Unfortunately, even though mammography
gives those with breast cancer positive outcomes, the
same cannot be said for those with invasive breast
cancers like TNBC. TNBC's growth is rapid due to its
lack of estrogen receptors, progesterone receptors, and
the HER2 protein. Treatment includes different therapies
and surgery; however, the prognosis is poor. Research is
still being performed to help those with TNBC have a
positive outcome. Women 40 years of age and older
should continue to get yearly mammograms to help
reduce their chances of breast cancer.

